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Abstract
Genome-scale network reconstructions are useful tools for understanding cellular metabolism, and comparisons of such
reconstructions can provide insight into metabolic differences between organisms. Recent efforts toward comparing
genome-scale models have focused primarily on aligning metabolic networks at the reaction level and then looking at
differences and similarities in reaction and gene content. However, these reaction comparison approaches are time-
consuming and do not identify the effect network differences have on the functional states of the network. We have
developed a bilevel mixed-integer programming approach, CONGA, to identify functional differences between metabolic
networks by comparing network reconstructions aligned at the gene level. We first identify orthologous genes across two
reconstructions and then use CONGA to identify conditions under which differences in gene content give rise to differences
in metabolic capabilities. By seeking genes whose deletion in one or both models disproportionately changes flux through a
selected reaction (e.g., growth or by-product secretion) in one model over another, we are able to identify structural
metabolic network differences enabling unique metabolic capabilities. Using CONGA, we explore functional differences
between two metabolic reconstructions of Escherichia coli and identify a set of reactions responsible for chemical
production differences between the two models. We also use this approach to aid in the development of a genome-scale
model of Synechococcus sp. PCC 7002. Finally, we propose potential antimicrobial targets in Mycobacterium tuberculosis and
Staphylococcus aureus based on differences in their metabolic capabilities. Through these examples, we demonstrate that a
gene-centric approach to comparing metabolic networks allows for a rapid comparison of metabolic models at a functional
level. Using CONGA, we can identify differences in reaction and gene content which give rise to different functional
predictions. Because CONGA provides a general framework, it can be applied to find functional differences across models
and biological systems beyond those presented here.
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Introduction
Advances in genome sequencing and computational modeling
techniques have sparked the construction of genome-scale network
reconstructions (GENREs) [1] for over 100 prokaryotic and
eukaryotic organisms [2]. These reconstructions describe the
functions of hundreds of metabolic genes, and enable a concise
mathematical representation of an organism’s biochemical capa-
bilities via genome-scale models. Constraint-based methods [3]
can then be applied to genome-scale models to understand and
predict cellular behavior. Genome-scale models are becoming a
common framework for representing genomic information, as
evidenced by recent works simultaneously reporting genome
sequences and metabolic models [4,5]. Efforts like the new Model
SEED database will facilitate this process, by enabling the rapid
construction and refinement of network reconstructions as genome
annotations change [6].
The abundance of genome sequences has led to advances in
comparative genomics, in which biological insight comes from
interrogation of genome structure and function across species. The
advent of tools such as the Model SEED paves the way for
functional comparison of genome-scale reconstructions, but
computational methods for comparing models at a functional
level have not yet emerged. Existing network comparison
approaches such as reconstruction jamborees [7,8] or metabolic
network reconciliation [9] compare models of the same or closely-
related organisms with the aim of identifying and reconciling
differences between models. These approaches rely on a manual
mapping of metabolic compounds and reactions across the
networks and then look at differences and similarities in reaction
and gene content to identify structural differences (e.g., the presence
or absence of particular genes or reactions). However, existing
approaches do not identify functional differences (e.g., differences in
organism behavior), or explain how structural differences impact
the functional states of the network (e.g., achievable rates of
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individually, and a number of simulations may be necessary before
functional differences arising from structural differences are
observed. Additionally, reaction alignment approaches can be
time-consuming, since biochemical databases (such as BiGG,
BioCyc, KEGG or SEED [10–13]) and model construction
platforms (such as Pathway Tools [14] or the Model SEED [6])
may use different nomenclatures or abbreviations to describe
metabolites and reactions.
We have developed a bilevel mixed-integer linear programming
(MILP) approach to identify functional differences between models
by comparing network reconstructions aligned at the gene level,
bypassing the need for a time-consuming reaction-level alignment.
We call this new constraint-based method CONGA, or Compar-
ison of Networks by Gene Alignment. We first use orthology
prediction tools (e.g., bidirectional best-BLAST) to identify sets of
orthologs in two organisms based on their genome sequences, and
then we use CONGA to identify conditions under which
differences in gene content (and thus reaction content) give rise
to differences in metabolic capabilities. Because orthologs often
encode proteins with the same function, we would expect their
gene-protein reaction (GPR) associations, and thus their associated
reactions, to be similar. Therefore, a gene-level alignment serves as
a proxy for a reaction-level alignment. By identifying genetic
perturbation strategies that disproportionately change flux through
a selected reaction (e.g., growth or by-product secretion) in one
model over another, we are able to functional differences (e.g.,
biomass yield) between the two organisms. Once these functional
differences are found, they can be further evaluated to identify
structural differences (e.g., gene and reaction differences) between
the organisms’ network reconstructions. By using an MILP
approach, we are able to identify these differences directly and
in an exhaustive fashion, without manually aligning all reactions in
the two networks.
We demonstrate that this approach can be used to study both
closely- and distantly-related organisms and to address a variety of
biological questions, by applying it to three pairs of organisms with
increasing phylogenetic distance. We first examine differences
between two published metabolic reconstructions of E. coli
metabolism, iJR904 [15] and iAF1260 [16]. The iAF1260 model
is an update to the iJR904 model, constructed to more accurately
reflect experimental data, including gene essentiality data and
growth phenotypes [17,18]. While both models have been used as
tools to help design new chemical production strains [19–22],
these two models have not been evaluated with respect to
differences in their metabolic engineering predictions. By identi-
fying knockout strategies where one model predicts a larger
chemical production rate than the other, we are able to determine
a small set of reactions responsible for predicted chemical
production differences between the two models.
We have also used CONGA to aid in the development of a
genome-scale network reconstruction of the photosynthetic
cyanobacterium Synechococcus sp. PCC 7002, which we name
iSyp611, by comparing it to the iCce806 reconstruction of
Cyanothece sp. ATCC 51142 [23]. Photoautotrophic microbes, such
as cyanobacteria, possess the ability to fix carbon dioxide and
transform light into chemical energy, making them strong
candidates for biofuel production hosts [24–27]. Through our
automated comparison, we also demonstrate the conserved aspects
of cyanobacterial physiology, and gain insight into the unique
properties of Synechococcus and Cyanothece.
Finally, we applied CONGA to compare the susceptibility of
distantly-related human pathogens to loss of metabolic enzymes.
We selected published networks of M. tuberculosis H37Rv [28] and
S. aureus N315 [29] and sought gene knockout strategies that are
predicted to be lethal in only one organism. We were then able to
identify differences in their metabolic networks which point to
unique metabolic functions as possible targets for organism-
specific antimicrobials. Such antibiotics are needed to expand the
limited scope of existing broad-spectrum antibiotics [30] and to
provide novel mechanisms of action which make the transfer of
resistance across species less probable [31–34]. We show that
many of the functions we identified have been experimentally
verified as essential, demonstrating that our computational
approach allows us to provide a list of candidate enzymes for
more focused study. As a component of this comparison, we used
three distinct orthology prediction tools to prepare a gene
alignment between the pathogens. We then analyzed the number
of false positive ortholog calls made by each method, and
examined the effect these incorrect orthology assignments had
on the results generated by CONGA.
Through these three case studies, we demonstrate that CONGA
can be used to rapidly compare metabolic networks regardless of
phylogenetic distance. We are also able to show that CONGA has
applications in metabolic engineering, model development, and
antibiotic discovery. We show that CONGA can facilitate
jamboree and network reconciliation efforts by pinpointing those
metabolic or genetic differences which give rise to differences in
model predictions.
Results
We have developed a bilevel mixed-integer linear programming
(MILP) approach, called CONGA, to identify functional differ-
ences between two networks by comparing network reconstruc-
tions aligned at the gene level. We have constructed an illustrative
example to demonstrate the types of functional differences
CONGA can identify. We then present three case studies and
demonstrate how CONGA results have implications in metabolic
engineering (comparison of E. coli models), model development
(comparison of cyanobacterial models), and drug discovery
(comparison of human pathogen models).
Identification of Network Differences via CONGA
CONGA identifies functional differences between two networks
by comparing network reconstructions aligned at the gene level.
The constraint-based method identifies gene deletion strategies
leading to different optimal flux distributions in the two networks.
CONGA calculates the flux difference between two reactions in
different models (e.g., Flux 1 in Species A minus Flux 2 in Species
B) and identifies deletions such that the specified flux difference is
maximized while both models are simultaneously maximizing
biomass (Figure 1).
We refer to a solution identified by CONGA as a gene deletion set.
CONGA can select any genes for deletion, with the restriction that
orthologous genes present in both models be deleted simulta-
neously from both models. We note that while CONGA can
calculate the flux difference between any two reactions, we believe
that selecting equivalent reactions (e.g., biomass) provides the most
useful objective for comparing models. Via manual investigation of
the results, we are able to classify gene deletion sets identified by
CONGA as arising due to one of four types of functional network
differences:
1. genetic differences, in which gene-protein-reaction (GPR) relation-
ships differ between models;
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identical functions cannot be assigned as orthologs (e.g., due to
sequence dissimilarity);
3. metabolic differences, where one organism has additional reactions
which enable it to carry out unique biochemical transforma-
tions; and
4. mixed differences, which arise due to some combination of types
1–3.
Using two example networks, we demonstrate the types of
functional differences CONGA can identify (Figure 2). Each
reaction network catalyzes the conversion of substrate (S) to
biomass (BM) and some by-product (P) (Figure 2A). We refer to
the two species as A and B, and the biomass- and by-product-
producing reactions as vBM and vP, respectively. Each pathway
producing biomass gives different yields for BM and P (Figure 2B),
though the optimal flux distributions maximizing biomass without
any gene deletions are identical in the two organisms (Figure 2C).
By applying CONGA with different objective functions, we can
identify gene deletion conditions under which network differences
become apparent (Figure 2D).
We first used CONGA to compute gene deletion sets
maximizing vBM in Species B over Species A (vBMB{vBMA). This
objective will be greatest when a gene deletion set is predicted to
be lethal in Species A and not in Species B. One such deletion set
contains the ortholog G12, which is present in both models
(Figure 2E). Under this deletion, growth becomes impossible in
Species A, whereas Species B has additional reactions which allow
it to convert I1 to B via metabolite I4. Thus, this gene deletion set
points to a metabolic difference between the two models. CONGA
can also be used to identify genetic differences (Figure 2F). For
instance, the deletion of GS1 is lethal only in Species A, because
Species B has an additional isozyme (GS1a) which carries out the
same transformation. Thus, this deletion set points to a genetic
difference. Other deletion sets point to orthology differences
(Figure 2G). For example, genes G23a and G23b are not orthologs
even though they carry out the same reaction. Thus, the deletion
of G2B and G23a is lethal in Species A, but Species B can still
carry flux through the reaction associated with G23b.
CONGA can also identify how metabolic differences affect
cellular phenotypes other than growth rate (Figure 2H). In this
example, the objective is to maximize the difference in flux
through vP in Species A over Species B (vPA{vPB). (The resulting
phenotypes for each model are analogous to production
phenotypes predicted by OptORF [35].) Deleting G2B forces
Species A to utilize the lower reaction pathway, producing 0.06
BM and 0.2 P per S. However, the optimal flux distribution for
Species B uses the upper reaction pathway, as this route produces
more biomass (0.08 BM per S vs 0.06 BM per S via the lower
pathway). As a consequence, Species A produces more by-product:
0.2 P per S in Species A vs. 0.1 P per S in Species B.
Because production values may not be unique at the maximum
growth rate, CONGA can artificially inflate flux differences
between models. This can only occur when the fluxes whose
difference is being maximzed (e.g., chemical production rates)
differ from the fluxes maximized by each model (e..g, biomass). In
this case, we impose a a tilt on the objective of the inner problem.
This tilt forces CONGA to identify deletions such that the
specified flux difference is maximized when the individual fluxes
through each reaction are at their lowest values that still support
maximum biomass production. See Methods for additional
details.
Comparison of E. coli Metabolic Models
We first used CONGA to compare two genome-scale metabolic
models of E. coli, the iJR904 model [15] and the iAF1260 model
[16]. The iAF1260 model extends the iJR904 model by
compartmentalizing the network (separating the cytoplasm and
periplasm), improving the biomass composition, and adding new
metabolic reactions. The iJR904 model has been used frequently
for metabolic engineering studies [36], but to our knowledge no
studies have examined the extent to which the iAF1260 model’s
additional metabolic content affects computationally derived strain
designs.
To explore the effect of the iAF1260 model’s larger network, we
used CONGA to identify gene deletion strategies for three
commonly studied fermentation products–ethanol, lactate, and
succinate–seeking identical knockout conditions where the
iAF1260 model predicted higher production rates than the
iJR904 model, and vice versa. We refer to such strategies as
model-dominant strategies. For example, an iAF1260-dominant
strategy is one in which the same gene deletion set predicts higher
chemical production in the iAF1260 model than in the iJR904
model. Because some of these knockout strategies result in
nonunique chemical production rates, model-dominant strategies
were identified with respect to the lowest possible production rate
consistent with the maximum growth rate.
Our initial CONGA results revealed a need to reconcile the
fermentation pathways between the two models, due to changes in
representation made in the iAF1260 model. We thus modified the
iJR904 model to reflect these changes and repeated the
simulations using the reconciled models. (See Dataset S2 for
details.) For ethanol, succinate, and lactate, we identified the top
three model-dominant strategies for each model for up to three,
four, and five knockouts, respectively. We observed that multiple
deletions are necessary to detect differences in production of these
latter metabolites, and the difference in yield does not improve
significantly beyond four or five knockouts, depending on the
Figure 1. Conceptual structure of the CONGA formulation.
CONGA employs a bilevel optimization problem to identify genetic
perturbations with nonidentical effects in each of two networks. The
outer problem is an MILP which finds gene deletions maximizing the
difference in flux value between two reactions in two different models.
The inner problems (in italics) are flux-balance analysis (FBA) problems
which ensure the flux difference is maximized while both models are
maximizing biomass. An optional tilt can be added to the inner
problem which forces the flux in the outer problem to the lowest value
that still support maximum biomass production. FBA imposes
constraints based on reaction stoichiometry, reaction directionality,
and enzyme capacities. GPR constraints associate genes to reactions
and are used to enforce the reaction deletions associated with the gene
deletions in the outer problem. CONGA can select any genes for
deletion, with the restriction that orthologous genes present in both
models be deleted simultaneously from both models. Finally, a limit
may be imposed on the total number of gene deletions.
doi:10.1371/journal.pone.0034670.g001
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transcriptional regulation, to identify the top three deletion
strategies for each model and product, for each number of gene
deletions. We refer to these strategies as OptORF strategies. These
strategies were then compared to the model-dominant strategies
identified by CONGA, to determine if optimal OptORF strategies
are likely to give similar or different predictions between the two
models.
The CONGA results for the model-dominant strategies for
ethanol production are presented in Figure 3A. We observed that
only 4 of the 16 (25%) model-dominant strategies were also
OptORF strategies (red bars), and none of the triple-deletion
model-dominant strategies were OptORF strategies. This suggests
that, when examining optimal OptORF strategies for higher
numbers of gene knockouts, either model’s predictions are likely to
be similar at the maximum growth rate. However, the models may
predict different ethanol production rates using the same gene
deletion set for strategies which do not result in the maximum level
of chemical production.
Figure 2. Application of CONGA to an example pair of metabolic networks. (A) In these two example networks, substrate (S) is utilized to
produce biomass (BM) and some by-product (P). We refer to the two species as A and B, and the biomass- and product-producing reactions as vBM
and vP, respectively. (B) List of genes and reactions present or absent in each network. All shared reactions have orthologs present in both networks,
except for the reaction associated with genes G23a and G23b, which are not orthologs. (C) A schematic view of the wildtype network behaviors in
which flux through vBM is maximized. (D) Gene deletion sets identified by CONGA for the stated CONGA objectives The first three objectives
maximize vBM in Species B over Species A. The last objective maximizes vP in Species A over Species B. The type of model difference (genetic,
orthology, or metabolic) associated with each deletion set is also given. (E through H) Schematic views of the flux distributions associated with each
gene deletion set in D. The optimal flux distributions in the example networks change as a result of the gene deletion sets in D. Differences in the
optimal flux distributions are due to differences in the two networks.
doi:10.1371/journal.pone.0034670.g002
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production of lactate and succinate were quite different (Figure
S1A and S2A). Here, 15 of the 30 model-dominant strategies are
also OptORF strategies. Of these 15 strategies, 13 are iJR904-
dominant strategies, with 11 involving the deletion of mphF and
adhC (thereby removing acetaldehyde dehydrogenase). When these
two genes are deleted, ethanol synthesis is no longer possible in the
iJR904 model, while the iAF1260 model can synthesize ethanol
via a second pathway (Figure 4A). The double deletion of mphF
and adhC enables iJR904-dominant strategies for lactate and
succinate production, with additional deletions determining
whether lactate or succinate is the dominant product. We also
observed that the iAF1260-dominant strategies for succinate
production are all of low-yield (less than 10% the theoretical
maximum). In fact, the iAF1260 model requires five gene deletions
to obtain yields greater than 10% of the theoretical maximum,
while the iJR904 model requires only two gene deletions. These
results demonstrate that CONGA can also be used to identify
differences in the ease of coupling growth to chemical production
in different models or organisms.
We then set out to investigate which network differences
between iJR904 and iAF1260 account for the production
differences associated with each gene deletion set found by
CONGA. Of the 46 total model-dominant strategies, 34 (74%)
could be attributed to at least one of six metabolic differences
between the two models (Table 1). The remaining 12 model-
dominant strategies predicted production differences of less than
10% the theoretical maximum yield, and in many cases much less.
Figure 3. Model-dominant production strategies for ethanol. (A) Deletion strategies for ethanol production. Each bar represents the absolute
difference in predicted ethanol yields between the iJR904 and iAF1260 models as a fraction of the maximum theoretical yield (2 ethanol/glucose).
Left side: Strategies for which the iAF1260 model predicts higher production. Right side: Strategies for which the iJR904 model predicts higher
production. Corresponding gene deletion strategies involving 1, 2, or 3 genes are given below the figure. Numbers above each bar indicate the
fraction of the theoretical maximum yield obtained by each model, with the dominant model listed first. Some strategies have a nonunique ethanol
production phenotype, in which multiple ethanol production values can occur at the maximum growth rate. For these scenarios, the production
difference calculated by CONGA is from the lowest expected level of ethanol production in each model, and such strategies are indicated in green.
Strategies for which the yield of the dominant model meets or exceeds the yield for the third-best OptORF strategy for that model are known as
OptORF strategies, and such strategies are indicated in red. (B) The same gene deletion strategies after reconciliation of the iJR904 and iAF1260
networks with respect to metabolic differences.
doi:10.1371/journal.pone.0034670.g003
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hexokinase) were associated only with iJR904-dominant ethanol
production strategies, while others were responsible for more than
one set of model-dominant strategies. For example, differences in
the succinate transport mechanism were implicated in strategies
associated with iAF1260-dominant production of ethanol and
lactate, and with iJR904-dominant production of succinate.
Many of these network differences affect the balance of possible
fermentation products (Figure 4 and Figure S3). For example, the
iAF1260 network contains an additional pathway to convert
acetyl-CoA to ethanol via L-2-amino-3-oxobutanoate and allo-
threonine (Figure 4A). As noted above, this extra pathway for
ethanol synthesis in the iAF1260 model carries flux in many of the
iJR904-dominant lactate and succinate production strategies,
demonstrating that a single network difference can be found
under multiple simulation conditions. In other instances, network
differences affect flux balances outside the central fermentation
pathways (Figure 4B). For example, when the genes edd (or eda),
tpiA, and fsaB are deleted, disrupting glycolysis and the Entner-
Doudoroff pathway, the iJR904 and iAF1260 models produce
different products. The iJR904 model converts glucose into ribose-
5-phosphate (r5p) via the oxidative and non-oxidative branches of
the pentose phosphate pathway. The r5p is then converted to
deoxyribose-5-phosphate and broken down into glyceraldehyde-3-
phosphate (g3p), which enters glycolysis, and acetaldehyde (acald),
which gets converted to ethanol. In contrast, the iAF1260 model
converts glucose to g3p and dihydroxyacetone phosphate (dhap).
As in the iJR904 model, g3p enters glycolysis, while dhap enters
the methylglyoxal (mthgxl) pathway. Some of the mthgxl is
converted to 1,2-propanediol (12 ppd) via a unique 12 ppd
synthesis pathway, while the remaining mthgxl continues through
the pathway to make pyruvate.
After identifying the metabolic differences that lead to model-
dominant strategies, we modified the iJR904 and iAF1260
networks to contain identical representations of each pathway
(Dataset S2) and re-evaluated the phenotype predictions of each
knockout strategy. After the network reconciliation, we found that
all but one of the knockout mutants are now predicted to have
similar production rates (Figure 3B, Figures S1B and S2B).
While other studies have identified functional differences
between the iJR904 and iAF1260 models with respect to growth
phenotypes (e.g., gene essentiality predictions [16]) using an
enumerative approach, here we compared the two reconstructions
with respect to their metabolic engineering predictions using an
algorithmic approach that identifies just those conditions resulting
in different model predictions. We hypothesized that coupling of
metabolites to biomass would be more difficult in the larger
iAF1260 model, and that the model might have higher production
levels (or larger production ranges if multiple products are
possible), due to the larger network containing more ways to
balance internal fluxes. These hypotheses were not borne out (with
the notable exception of coupling succinate production to
biomass), as we were able to predict similar production levels
using both models. In fact, the production differences we did
observe were due to only 21 reactions that represent just 3.5% of
the 594 unique metabolic reactions in the iAF1260 model
(described previously in [16]).
Cyanobacterial Metabolic Differences
Having analyzed two models of the same organism, we then
sought to analyze two models of closely related but distinct
organisms, and to examine organisms less well-studied than E. coli,
to see if CONGA can be used to generate new physiological
insights. For this application, we selected two cyanobacteria,
Synechococcus sp. PCC 7002 and Cyanothece sp. ATCC 51142. Very
few genome-scale metabolic reconstructions of cyanobacteria have
been published to date [37–39], and our group has recently
developed two more, the iSyp611 model of Synechococcus (this
paper) and the iCce806 model of Cyanothece [23]. In order to gain
insight into the metabolic similarities and differences between
these two cyanobacterial strains, we used CONGA to identify gene
Figure 4. Flux maps illustrating differences in metabolic
pathways in E. coli GENREs. The text above each map indicates
the pathway responsible for the phenotypic difference, the phenotype
with which the strategy is associated, and the gene deletion for which
the phenotype occurs. (A–B) Schematic views of the flux distributions
associated with the indicated gene deletion set. Metabolites are
represented in plain text. Metabolic transformations are indicated via
arrows, with thicker arrows indicating higher flux. In some instances,
multiple transformations are combined into a single dashed arrow or
lumped into a subsystem. Subsystems are indicated by plain text
enclosed in a grey rectangle. Fluxes active in the iAF1260 network are in
red, fluxes active in the iJR904 network are in blue, and inactive fluxes
are in grey. If gene (reaction) deletions occur in the fermentation
pathway, they are indicated by black ‘X’s. Fluxes crossing the dashed
boundary indicate transport to the extracellular environment. Metab-
olite abbreviations: 12 ppd, 1,2-propanediol; 2aobut, L-2-Amino-3-
oxobutanoate; actp, acetyl phosphate; athr, allo-threonine. All other
abbreviations match those used in the iSyp611 metabolic model (see
Dataset S2).
doi:10.1371/journal.pone.0034670.g004
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cyanobacterial metabolic model, as well as to improve our draft
Synechococcus reconstruction.
We first applied CONGA to the draft iSyp611 model. Some of
the gene deletion sets identified by CONGA arose due to missing
genes in the draft iSyp611 model. For example, CONGA
identified gene deletion sets containing protein synthesis enzymes
present only in the iCce806 network. Synechococcus also has these
proteins, but they had not been included in the model. Other
network differences arose due to incomplete GPR associations in
the draft iSyp611 model. For example, the iCce806 model
associated HisB with both histidinol-phosphatase and imidazole-
glycerol-phosphate dehydratase, while the draft iSyp611 network
only associated the protein with histidinol-phosphatase. The
original annotation indicated the gene was bifunctional, and the
draft iSyp611 model was updated accordingly. This approach
increased the size of the iSyp611 model from 542 to 611 genes, an
increase in gene content of 13%. This increase in gene content is
comparable to that seen in metabolic network reconciliation [9],
which was used to expand the gene content of genome-scale
models of Pseudomonas aeruginosa and Pseudomonas putida by 3% and
18%, respectively.
After refining the draft model based on these results, the
resulting model (iSyp611) was compared again to iCce806 using
CONGA. We identified 30 gene deletion sets that are lethal only
in the iSyp611 model and 36 gene deletion sets that are lethal only
in the iCce806 model (Table 2). We found that in many instances
different gene deletion sets mapped to the same set of reaction
deletions (or reaction deletion set). For example, we identified six gene
deletion sets lethal in the iSyp611 model that all mapped to
photosystem II. As a result of these and other redundancies, the 30
gene deletion sets for the iSyp611 model reduced to 20 unique
reaction deletion sets, and the 36 gene deletion sets for the iCce806
model reduced to 18 unique reaction deletion sets.
Of the four types of functional network differences, we were
most interested in metabolic differences, although the other types
are also important. For example, genetic differences may occur
because the genes encoding an essential protein have not yet been
identified in one organism. In total, the metabolic differences
accounted for 4 of 30 gene deletion sets (or 2 of 20 reaction
deletion sets) for the iSyp611 model and 10 of 36 gene deletion sets
(or 5 of 18 reaction deletion sets) for the iCce806 model (Table 3).
Two of the reaction deletion sets which are lethal only in the
iCce806 model require deletion of two reactions from both models
(Figure 5). In the first deletion set (Figure 5A), deletion of
glutamate dehydrogenase and glutamate synthase prevents the
iCce806 model from synthesizing glutamate. The iSyp611 model
has a unique reaction, valine amino-transferase (VPAMT), which
allows it to recover from this double deletion (blue arrows). In the
second deletion set (Figure 5B), deletion of pyruvate kinase and
malate dehydrogenase prevents the iCce806 model from making
pyruvate. The iSyp611 model has another unique reaction,
aspartase (ASPT), which enables it to produce pyruvate and
recover from the double deletion. A search of the Cyanothece
genome failed to reveal candidate genes for ASPT and VPAMT,
lending support to the hypothesis that they may be true metabolic
differences between the two cyanobacteria.
CONGA reveals differences that can be used to reconcile and
improve genome-scale metabolic models of closely-related species.
We intend to use the remaining genetic and orthology differences
found by CONGA as a starting point in further updating our
reconstruction, as they may indicate missing or incorrectly
annotated genes. CONGA can also identify differences in
metabolic capabilities between models: our analysis here indicates
Synechococcus and Cyanothece share a significant number of pathways,
with important differences in central and amino acid metabolism.
Drug Targeting in Human Pathogens
While were able to idenitfy metabolic differences between the
two cyanobacteria, many of the differences identified by CONGA
were not due to reaction-level differences. We thus sought to use
CONGA to explore differences in metabolic capabilities between
two dissimilar oganisms, and to exploit those differences to identify
organism-specific drug targets. For this application, we applied
CONGA to existing models of two phylogenetically distant human
pathogens, the iNJ661 model of M. tuberculosis [28] and the iSB619
model of S. aureus [29], in order to explore differences in
pathogenicity and drug resistance based on differences in reaction
Table 1. Explanation of metabolic differences between the iJR904 and iAF1260 models of E. coli.
Metabolic Difference Description of Metabolic Difference Functional Effect
1,2-Propanediol Synthesis The iAF1260 model has the ability to secrete
1,2-propanediol; the iJR904 model does not.
The ability to convert glucose to 1,2-propanediol gives the iAF1260 model
greater flexibility in choosing fermentation products under some conditions.
Aldehyde Dehydrogenase The iAF1260 model has a unique aldehyde
dehydrogenase which the iJR904 model lacks.
This reaction grants the iAF1260 model the ability to convert acetaldehyde to
acetate using NADP. This reaction was selected for deletion by CONGA in iJR
dominant strategies, but was never directly implicated in a solution.
Ethanol Synthesis The iAF1260 model has unique reactions to
convert acetyl-CoA to acetaldehyde which
the iJR904 model lacks.
Deletions are possible in which the iJR904 model produces no ethanol while
the iAF1260 model produces ethanol at high levels.
Hexokinase The iAF1260 model has a unique hexokinase
that it can use as an alternative to
phosphoglucose isomerase (PGI).
The iAF1260 model has the ability to recover from multiple-reaction deletions
containing PGI, while the iJR904 model does not.
Hydrogen Transport The iAF1260 model has the ability to secrete
hydrogen gas; the iJR904 model does not.
The ability to secrete hydrogen gas allows the iAF1260 model to convert formate
to CO2 and H2, consuming a proton in the process. This provides the iAF1260
model an additional way to consume cytoplasmic Hz, and changes the preferred
fermentation products under some conditions.
Succinate Transport The iAF1260 model employs a hydrogen
antiporter for succinate; the iJR904 model
employs a hydrogen symporter.
Production of succinate becomes less energetically favorable in the iAF1260 model,
as the synthesis route consumes fewer cytoplasmic protons.
Six metabolic differences accounted for the majority of the model-dominant strategies identified by CONGA.
doi:10.1371/journal.pone.0034670.t001
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models, we sought genetic perturbation strategies that were
predicted to be lethal in only one organism.
Our preliminary analysis identified a total of 168 unique gene
deletion sets, of which 139 (83%) could be traced in whole or in
part to genetic or orthology differences. As these differences made
up the majority of identified differences, we manually evaluated
the quality of the orthology assignments and the original GPR
associations. This analysis resulted in the modification of the GPR
associations for 19 reactions in the iSB619 model and 36 reactions
in the iNJ661 model (Dataset S2). As a result of these changes, 7
genes were eliminated from and 3 added to the iSB619 model,
with 10 genes eliminated from and 4 added to the iNJ661 model.
A number of these initial genetic- and orthology-related gene
deletion sets arose due to different representations of the glycine
cleavage complex (GCC) and pyruvate dehydrogenase system
(PDH) in the two models (Figure 6A). Both GCC and PDH are
composed of three separate enzymes (a, b, and c), each of which
carries out a distinct catalytic activity. Deletion of GCC is
predicted to be lethal in both organisms, and because one subunit
is shared by GCC and PDH, deletions to one complex may affect
the other. In its original form, the iSB619 reconstruction modeled
PDH as an overall reaction, and GCC via its three individual
reactions (Figure 6B). In contrast, the iNJ661 model represented
both PDH and GCC as individual and overall reactions
(Figure 6B). Due to these differences, a number of ortholog
deletions are lethal in only one model. For example, deletion of the
ortholog pair (SA0945, Rv2495) deletes PDH from the iSB619
network, but only deletes PDHb from the iNJ661 network. The
deletion is lethal only in the iSB619 model. We thus revised the
GPR associations for these complexes to give a consistent
representation between the two models (Figure 6C). These
changes also required changes to the stoichiometric matrices in
each model. (See Dataset S2 for details.)
We applied CONGA again after this initial reconciliation, and
identified 71 gene deletion sets lethal only in the iSB619 model
and 84 gene deletion sets lethal only in the iNJ661 model (Table 4).
Of these, a total of 99 gene deletion sets (64%) were still due to
genetic or orthology differences. Nevertheless, CONGA identified
18 gene deletion sets arising from metabolic differences which
were lethal only in the iSB619 model, and 38 such gene deletion
sets lethal only in the iNJ661 model. As with the cyanobacteria, in
some instances multiple gene deletion sets mapped to the same
reaction deletion set (Table 4). Of these, we examined only those
gene deletion sets arising from metabolic differences, and
identified 17 unique reaction deletion sets lethal only in the
iSB619 model and 28 unique reaction deletion sets lethal only in
the iNJ661 model.
These 45 unique reaction deletion sets served as the starting set
of potential drug targets. We employed a multi-step process to
reduce these reaction deletion sets to a set of candidate antibiotic
targets. First, because genes may be associated with more than one
reaction, we eliminated from each unique reaction deletion set any
reactions that were nonessential to the set. For example, CONGA
identified the deletion of SA1487 as lethal in S. aureus, leading to
the reaction deletion set DHFS and THFGLUS. However, the
deletion of THFGLUS is not lethal, so THFGLUS was removed
from the reaction deletion set, giving the reduced reaction deletion
set DHFS. We then examined the reduced reaction deletion sets
and eliminated those sets where more than one reaction deletion
was required to give a lethal prediction. Such reaction deletion sets
are likely to be poor candidates for potential drug targets, because
they may require development of a multiple-drug treatment
strategy. For example, CONGA identified the reaction deletion set
RNDR1, RNDR4 as being lethal in M. tuberculosis, with both
reaction deletions necessary to give a lethal prediction. This set
was subsequently eliminated from the set of candidate antibiotic
targets. Finally, we eliminated those reactions included in the
Recon 1 genome-scale metabolic model of human metabolism
[40], as drugs targeting these reactions may cause adverse side-
effects in humans. This procedure yielded 10 reactions as
candidate antibiotic targets in S. aureus and 37 reactions as
candidate antibiotic targets in M. tuberculosis (Table 5).
Table 2. Number of lethal gene deletion sets for the cyanobacterial models iSyp611 and iCce806. Numbers in parentheses
correspond to unique reaction deletion sets.
iSyp611 iCce804 Interpretation Example
Genetic 20 (12) 22 (9) A gene-protein-reaction (GPR) relationship differs between
models.
The iSyp611 model has a unique
isozyme for phosphoglucomutase.
Orthology 4 (4) 4 (4) Genes encoding enzymes with identical functions cannot be
assigned as orthologs.
Both organisms have annotations for
dihydroorotase, but the genes are not
matched as orthologs due to
sequence dissimilarity.
Metabolic 4 (2) 10 (5) One organism has an additional reaction which enables
it to carry out a unique biochemical transformation.
The double deletion of glutamate
dehydrogenase and glutamate
synthase is lethal only in the iCce806
model.
Mixed 2 (2) 0 (0) More than one of the above types is implicated in the
predicted phenotype difference.
The Synechococcus gene for malic
enzyme (NADP-catalyzed) is predicted
to be an ortholog to the Cyanothece
gene for malic enzyme (NAD-
catalyzed) (orthology difference). The
iCce806 has both NAD- and NADP-
catalyzed versions of malic enzyme
(metabolic difference).
Total 30 (20) 36 (18)
Functional network differences were classified into one of four types based on their biological interpretation. In many cases, different gene deletion sets led to the same
reaction deletion set. The number of unique reaction deletion sets is given in parentheses.
doi:10.1371/journal.pone.0034670.t002
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existing antibiotics (Table 5), demonstrating that our approach can
correctly identify candidate metabolic functions for drug targeting.
Most of the reactions for which antimicrobials exist are involved in
cell wall and cell membrane synthesis. While both organisms
require these biosynthetic capabilities, their cell walls and
membranes are structurally different, and so different proteins
and reactions are required. These differences are reflected in the
standard antimicrobial treatments for these two pathogens. For
example, vancomycin binds to the D-alanine terminus of
peptidoglycan and prevents the incorporation of teichoic acids
into the matrix [41]. Mycobacteria, such as M. tuberculosis, have
structurally distinct cell walls, for which isoniazid, ethambutol, and
pyrazinamide are required treatments [42–44]. We were also able
to find reports of small molecule inhibitors of fatty acid synthesis in
both S. aureus [45,46] and M. tuberculosis [47].
Table 3. Explanation of metabolic differences between the cyanobacterial models iSyp611 (Synechococcus) and iCce806
(Cyanothece).
Reaction Deletion Set Lethal In Explanation of Metabolic Difference
PDH iSyp611 Acetyl-CoA synthase (ACS), pyruvate dehydrogenase
(PDH), and phosphotransacetylase (PTA) are responsible
for acetyl-CoA synthesis. The iSyp611 model requires
PDH to supplement the activity of ACS, while the
iCce806 model requires PTA. Thus, the deletion of PDH is
lethal only in the iSyp611 model.
MDH and ME2 iSyp611 Fumarate, produced as a byproduct of arginine
biosynthesis, is converted to malate and then to
oxaloacetate (by malate dehydrogenase, MDH). In the
absence of MDH, malic enzyme (ME) can instead convert
malate to pyruvate. The iSyp611 model contains NADP-
catalyzed malic enzyme (ME2), while the iCce806 model
contains both NADP- (ME2) and NAD-catalyzed (ME1)
malic enzyme. Thus, the deletion of MDH and ME2 is
lethal only in the iSyp611 model.
ASNS1 iCce806 This reaction synthesizes asparagine. The iSyp611 model
does not contain this reaction, because Synechococcus
instead aminates aspartyl-tRNA to asparaginyl-tRNA prior
to protein synthesis.
PQPCOR iCce806 Cyanothece is unique among the two cyanobacteria in
using plastocyanin during photosynthesis. Hence, the
iCce806 model contains the reaction PQPCOR, while the
iSyp611 model does not.
PTA iCce806 Acetyl-CoA synthase (ACS), pyruvate dehydrogenase
(PDH), and phosphotransacetylase (PTA) are responsible
for acetyl-CoA synthesis. The iCce806 model requires
PTA to supplement the activity of ACS, while the iSyp611
model requires PDH. Thus, the deletion of PTA is lethal
only in the iCce806 model.
GLUD and GLUS iCce806 GLUD (glutamate dehydrogenase) and GLUS (glutamate
synthase) synthesize glutamate from alpha-
ketoglutarate. This step incorporates ammonia into the
metabolism and begins amino acid synthesis. The
iSyp611 model has an extra reaction, valine-pyruvate
aminotransferase (VPAMT), which allows it to recover
from this deletion. Under the deletion scenario,
ammonia gets combined with pyruvate to make alanine.
Alanine is converted to valine which in turn is convered
to glutamate.
MDH and PYK iCce806 Pyruvate synthesis is necessary to meet biomass
demands. Pyruvate is normally synthesized from
phosphoenolpyruvate via pyruvate kinase (PYK). In the
absence of PYK, pyruvate can be synthesized from
malate. Malate is produced as a result of biomass
demands for arginine and tetrahydrofolate, but in
insufficient levels to meet demand. Malate
dehydrogenase (MDH) can make up for the demand by
converting oxaloacetate to malate. As a consequence,
deletion of both genes is lethal. The iSyp611 model has
the unique reaction aspartase (ASPT), which it can use
instead of MDH to convert oxaloacetate to malate, by
way of aspartate. As a consequence, MDH function is no
longer required in the absence of PYK, and the double
deletion is nonlethal.
We identified two unique reaction deletion sets lethal only in the iSyp611 model, and five unique reaction deletion sets lethal only in the iCce806 model. From these, we
identified seven metabolic differences between the two models.
doi:10.1371/journal.pone.0034670.t003
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antibiotics do not yet target. For example, the iSB619 model
requires tetrahydrofuran (THF) and NAD to produce biomass.
Unfortunately, many staphylococci are already resistant to
inhibitors of THF synthesis [48], while inhibitors of the
nicotinamidases S. aureus uses for NAD synthesis have only
recently been identified [49]. However, M. tuberculosis can grow in
media lacking THF and NAD [28], suggesting the lack of THF
and NAD in the iNJ661 biomass equation may reflect a model
development choice, rather than a biological difference. We
identified M. tuberculosis’ unique use of siderophores for iron
transport, for which biosynthesis inhibitors have been identified
[50]. We also identified mycobacteria’s use of unique glycolipids,
but we were unable to identify inhibitors that have been reported
in the literature, making glycolipid synthesis a potential new target
for new M. tuberculosis-specific antibiotics. Of the remaining
organism-specific metabolic functions, two candidate antibiotic
targets (nicotinamidase in S. aureus and siderophore synthesis in M.
tuberculosis) had not been identified by previous computational
studies of these models [28,29].
By comparing pathogens against each other, we are able to
identify essential functions unique to a particular pathogen. This
enables the identification of narrow-spectrum antibiotics tailored
to individual pathogens. It is believed that the use of such
antibiotics can overcome multi-drug resistance through novel
mechanisms of action [32,33] and slow the rate of resistance
transfer across species [31,34]. We believe our framework provides
a rapid means of identifying unique metabolic functions as possible
targets for new antimicrobials, and will provide a useful tool for
combating the rapid rise of multi-drug resistant bacteria.
Assessment of Ortholog Calling Methods
Before CONGA can be applied to a pair of metabolic models, a
gene-level alignment must be performed. We perform this
alignment by identifying the orthologous genes between the two
models, and we force CONGA to select ortholog pairs as a single
unit. Prior to applying CONGA to the pathogen models, we
examined three methods for identifying orthologous genes
(Figure 7). The first method utilized a BLAST search [51] to
identify those pairs of M. tuberculosis and S. aureus genes which were
mutual best-BLAST hits of each other, called bidirectional best-
BLAST hits. An E-value of 10{5 was employed as a cutoff. The
second method used OrthoMCL [52] to identify pairs of genes
belonging to the same ortholog group (a cross-taxa group of genes
in which all genes are bidirectional best-BLAST hits of one
another). The last method utilized the SEED [13] to identify genes
belonging to the same FIGfam (sets of proteins homologous along
their entire length).
We first identified ortholog pairs where both the M. tuberculosis
and S. aureus genes were included in the iNJ661 and iSB619
models, respectively. We found that the number and content of
ortholog calls depended on the method used (Figure 7A). The
bidirectional best-BLAST search identified a total of 287 of a
possible 619 genes. SEED identified the fewest, with only 229
orthologs. Of these, 175 orthologs were common to all methods,
with smaller numbers of orthologs being shared by pairs of
methods.
We also analyzed the three methods for false positive ortholog
calls (Figure 7B). A false positive ortholog call is one in which two
orthologs are associated with different reactions in their respective
models. We found that all three methods identified 7 ortholog
pairs for which model annotations were distinctly different
(Table 6). SEED identified the fewest additional false positives,
giving 14 total. Full details of orthologs assigned by each method
Figure 5. Identified metabolic differences in cyanobacteria. (A)
Top: Pathways for synthesis of glutamate (glu) from alpha-ketoglutarate
(akg) used in iCce806. Bottom: Pathway predicted by the iSyp611 model
when glutamate dehydrogenase (GLUD) and glutamate synthase (GLUS)
are deleted. Valine aminotransferase (VPAMT) enables the synthesis of
glutamate from pyruvate (pyr). (B) Top: Pathway for conversion of
phosphoenolpyruvate (pep) to pyruvate when pyruvate kinase (PYK) is
deleted from iCce806. Bottom: Pathway predicted by the iSyp611 model
when malate dehydrogenase (MDH) is also deleted. Aspartase (ASPT)
allowsmalate (mal)tobesynthesizedentirelyfromfumarate(fum),rather
than from fumarate and oxaloacetate (oaa). (A and B) Red arrows
indicate flux in the iCce806 model. Blue arrows represent flux in the
iSyp611 model under the indicated knockout condition. Black arrows
indicate inactive reactions and reaction deletions are indicated by black
‘X’s. Gray arrows (top panels) indicate reactions not present in the
iCce806 model. Arrow thickness corresponds to relative flux levels.
Reaction and metabolite abbreviations are identical in the iSyp611 and
iCce806 models and are given in Dataset S2.
doi:10.1371/journal.pone.0034670.g005
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ortholog calling method on the gene deletion sets identified by
CONGA. We found that using orthologs identified by bidirec-
tional best-BLAST and OrthoMCL yielded numerous gene
deletion sets containing false positive ortholog pairs. In contrast,
the number of gene deletion sets containing true ortholog pairs
was relatively insensitive to the method used to call orthologs. We
thus chose to perform all simulations using SEED orthologs.
Using the orthologs identified by SEED, we then assessed the
metabolic overlap between the two models (Figure 7C). In
addition to the 224 orthologs present in both models, the
iSB619 model contains 33 genes with orthologs that are not
included in the iNJ661 model, and the iNJ661 model contains 13
genes with orthologs that are not in the iSB619 model. These 46
genes can likely be used to expand the scope of each model.
Additionally, we identified 253 orthologs included in neither
model. Using SEED, we were able to classify these 253 orthologs
into subsystems and found that 45% were involved in protein,
DNA, or RNA metabolism, while 15% were involved in non-
metabolic functions such as cell division, regulation, and the stress
response. An additional 22% were of unknown or uncertain
function. The remaining 18% were spread across a variety of
metabolic subsystems, with 35 of the 253 (8%) orthologs being
involved in vitamin and cofactor synthesis. Many of these 35 genes
are involved in the assembly of metal clusters and would not
generally be included in a metabolic model. Finally, we observed
that metabolic genes are enriched for members of an ortholog
pair: 37% (229 of 619) of genes in the iSB619 model had orthologs
Figure 6. Example adjustment of pathogen models following preliminary analysis. (A) Original model annotations for the glycine cleavage
(GCC) and pyruvate dehydrogenase (PDH) complexes. Green boxes represent reactions and gray boxes represent genes. S. aureus loci are in blue text
and M. tuberculosis loci are in red text. Dashed lines indicate orthologs and solid lines connect genes to reactions. SA1365 and SA1366 are
orthologous to the N-terminus and C-terminus of Rv1832, respectively, and together are orthologous to the entire Rv1832 sequence. A ‘+’ sign
between genes indicates a complex; a ‘/’ sign indicates isozymes. (B) The two models were inconsistent in their representation of these two enzyme
complexes. This table indicates the presence or absence of individual (a, b, c) and lumped (GCC, PDH) reactions before and after model adjustments.
The shaded gray boxes indicate the presence of a particular function, and the small black text indicates that model’s specific reaction. (C) Revised
model annotations for the GCC and PDH complexes. The color scheme is the same as in A.
doi:10.1371/journal.pone.0034670.g006
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S. aureus genome had orthologs in the M. tuberculosis genome
(x2 P{valuev0:001).
Discussion
In this work, we developed a bilevel mixed-integer program-
ming approach to identify the functional differences between
networks by comparing network reconstructions aligned at the
gene level. The constraint-based method first identifies a set of
orthologous genes based on genome sequence, and then identifies
conditions under which differences in gene content give rise to
differences in metabolic capabilities. Our gene-centric approach
allows for the rapid identification of functional differences between
networks which can be traced back to the presence or absence of
particular genes or reactions (structural differences) in one network or
the other. We demonstrate that our algorithm can be used to
identify genetic, orthology, and metabolic differences between
reaction networks with applications in metabolic engineering,
model development, and antibiotic discovery.
Increasingly, new genome-scale reconstructions are being
created by identifying bidirectional best-BLAST hits against
genomes for which models have already been constructed. GPR
and reaction annotation information can then be copied into the
Table 4. Number of lethal gene deletion sets for the human pathogen models iSB619 and iNJ661. Numbers in parentheses
correspond to unique reaction deletion sets.
iSB619 iNJ661 Interpretation Example
Genetic 3 (3) 13 (8) A gene-protein-reaction (GPR) relationship differs between models. Only the iSB619 model has a gene associated with
sulfur reductase.
Orthology 17 (17) 14 (14) Genes encoding enzymes with identical functions can- not
be assigned as orthologs.
Both organisms have putative annotations for
chorismate mutase, which are not matched as
orthologs due to sequence dissimilarity.
Metabolic 18 (17) 38 (28) One organism has an additional reaction which enables it to
carry out a unique biochemical transformation.
The deletion of homoserine kinase is lethal only in
the iSB619 model.
Mixed 33 (26) 19 (11) More than one of the above types is implicated in the
predicted phenotype difference.
Only the iNJ661 model has a gene associated with
phosphoserine transaminase (genetic difference).
This reaction deletion is nonlethal in the iSB619
model because it can utilize alternative pathways
to perform this function (metabolic difference).
Total 71 (63) 84 (61)
Functional network differences were classified into one of four types based on their biological interpretation. In many cases, different gene deletion sets led to the same
reaction deletion set. The number of unique reaction deletion sets is given in parentheses.
doi:10.1371/journal.pone.0034670.t004
Table 5. Potential drug targets in the human pathogens S. aureus and M. tuberculosis.
Organism Reaction Deletion Set Subsystem Known Drugs
S. aureus ALATA_D Cell wall synthesis Vancomycin [41]
S. aureus DHFS Cofactor synthesis Trimethoprim and Sulfonamides [48]
S. aureus KAS11 or KAS12 or KAS13 Cell membrane synthesis Small molecules [45,46]
S. aureus NNAM Cofactor synthesis Small molecules [49]
S. aureus TECA1S or TECA2S or TECA3S or TECA4S Cell wall synthesis Vancomycin [41]
M. tuberculosis CHRPL Cell membrane synthesis None
M. tuberculosis FACOAL80 or FACOAL160 or FACOAL200 or
FACOALPHDCA
Cell wall synthesis Small molecules [17]
M. tuberculosis FAS80_L or FAS100 or FAS120 or FAS140 or
FAS160 or FAS180 or FAS200 or FAS240_L or
FAS260 or FASPHDCA
Cell wall synthesis Pyrazinamide [42]
M. tuberculosis FASm220 or FASm240 or FASm260 or
FASm280 or FASm300 or FASm320 or
FASm340 or FASm2201 or FASm2202 or
FASm2401 or FASm2402 or FASm2601 or
FASm2602 or FASm2801 or FASm2802
Cell wall synthesis Isoniazid [43,44]
M. tuberculosis MCBTS Siderophore synthesis Small molecules [50]
M. tuberculosis PREPPACPH Cell membrane synthesis None
M. tuberculosis PPTGS or PPTGS_TB1 or PPTGS_TB1 or UDCPDP Cell wall synthesis Ethambutol [43,44]
We identified five unique reaction deletion sets lethal only in the iSB619 model, and seven unique reaction deletion sets lethal only in the iNJ661 model. From these, we
identified 10 candidate antibiotic targets in S. aureus and 37 candidate antibiotic targets in M. tuberculosis. Antibiotics targeting some of these reactions have already
been developed.
doi:10.1371/journal.pone.0034670.t005
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possible challenges with this approach. First, a bidirectional best-
BLAST search might not identify all orthologs: the iSyp611 model
was constructed from a draft iCce806 model containing 591 genes.
Orthologs for 537 of these genes were copied to the iSyp611
model, representing a 9% gene loss. Of the 54 Cyanothece genes for
which a bidirectional best-BLAST search did not identify
orthologs in Synechococcus, manual curation identified orthologs
for 26 of them. While these orthologs were not bidirectional best-
BLAST hits, we decided the genes had sufficiently high sequence
similarity and sufficiently similar annotations to be considered
orthologs. (Annotations were collected from NCBI, the Kyoto
Encyclopedia of Genes and Genomes (KEGG) [12], and SEED
[13].) This suggests that construction of new models using only
bidirectional best-BLAST hits may exclude significant numbers of
genes from new reconstructions. Second, using bidirectional best-
BLAST hits to identify orthologs may also generate large numbers
of false positive ortholog pairs. Our bidirectional best-BLAST
comparison of the manually curated S. aureus and M. tuberculosis
models yielded 41 false positives (14% of the 287 orthologs, where
a false positive indicates orthologs were associated with different
metabolic reactions). If one model had been created from the
other, these genes would have incorrect reactions associated with
them. Manual assessment of the cyanobacterial bidirectional best-
BLAST hits yielded 35 (of 537, or 7%) false positive orthologs in
the draft iSyp611 model, which were subsequently removed from
the final reconstruction. Thus, false positive ortholog calls
represent a significant problem even for closely-related organisms.
Our approach represents a significant advance in comparing
genome-scale network reconstructions. CONGA is a single
instance of a broader approach, in which two different networks
are compared and analyzed for functional differences. This
represents a significant advance over existing model-comparison
approaches [7–9], which typically do not identify the effect of
network differences on achievable functional states. However,
CONGA is not a replacement for more exhaustive approaches
such as jamborees or network reconciliation: CONGA will not
lead to the identification of all structural differences between
models, just those causing different functional states. For example,
a reaction-level alignment of the iSyp611 and iCce806 models
identified 172 reactions unique to the iCce806 model and 57
reactions unique to the iSyp611 model. Of these 229 reaction
differences, 126 cannot be utilized under the photoautotrophic
conditions studied here. Of the remaning 113 unique reactions,
only 15 were identified by CONGA as leading to differences in
gene essentiality in the two cyanobacterial models under carbon-
limited photoautotrophic conditions (when all genes are consid-
ered for deletion). Additional reaction differences could be picked
up by CONGA if other environments (e.g., dark fermentation),
growth conditions (e.g., suboptimal instead of lethal gene
deletions), and objective functions (e.g, chemical production rates)
Figure 7. Comparison of ortholog identification methods for S.
aureus and M. tuberculosis. (A) Number of model genes identified as
orthologs by each of the three methods. Only the orthologs present in
both models are included in the diagram. Overlapping areas indicate
orthologs identified by one or more methods. (B) Number of false
positive orthology assignments made by each of the three methods. A
false positive orthology assignment indicates the two genes are
associated with different reactions in their respective models.
Overlapping areas indicate false positives identified by one or more
methods. (C) Overlap of gene content between the two pathogens,
based on SEED FIGfams. Smaller circles represent genetic content of the
two models, with the larger circles representing the entire genome.
Numbers within overlapping areas indicate numbers of orthologs.
doi:10.1371/journal.pone.0034670.g007
Table 6. False positive ortholog calls in the iSB619 (S. aureus) and iNJ661 (M. tuberculosis) human pathogen models.
S. aureus M. tuberculosis
Locus Reaction Locus Reaction
SA0486 Glutamyl-tRNA synthetase Rv2992 Alanyl-tRNA synthetase
SA0760 Glycine cleavage complex, subunit B Rv1826 Glycine cleavage complex, entire complex
SA1059 Methionyl-tRNA synthetase Rv1406 Methionyl-tRNA formyltransferase
SA1131 2-oxoglutarate synthase Rv2455 Ferredoxin oxidoreductase
SA1132 2-oxoglutarate synthase Rv2454 Ferredoxin oxidoreductase
SA1519 L-alanine, glycine, and L-serine transport via ABC system Rv1704 D-alanine, D-serine, glycine, and L-serine transport via
proton symport
SA2467 Imidazole-glycerol-3-phosphate synthase Rv1602 Glutamine phosphoribosyldiphosphate
amidotransferase
All three methods for assigning ortholog pairs identified seven pairs of orthologs which carried out different functions in the iSB619 and iNJ661 models.
doi:10.1371/journal.pone.0034670.t006
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association) could be deleted as well (since 20 of the 229 unique
reactions did not have GPR associations). Despite the inability to
identify all structural differences, CONGA can identify those gene
(and thus reaction) differences which give rise to differences in
predicted growth and production rates, as well as other
phenotypes. As a result, we believe that it will be a useful tool to
complement existing model reconciliation and comparison efforts,
such as jamborees.
While this work identified gene deletions pointing to functional
metabolic differences, other network perturbations may be equally
effective indicators of network differences. Robust algorithms for
identifying other types of perturbations have also been developed
[35,58–63] and can be easily incorporated into CONGA.
Furthermore, gene and reaction differences may not be the only
source of differences between models, differences in the represen-
tation (abstraction) of the underlying biology may also play a role.
For example, the iAF1260 model includes a periplasmic space and
an explicit (instead of lumped) representation of fatty-acid
biosynthesis. Many of the reaction differences between the
iJR904 and iAF1260 models arise due to these differences in
model abstraction. In such a scenario, a reaction-alignment
approach may be challenging, whereas using CONGA we can
identify how these abstraction differences affect model predictions.
CONGA can also be used to examine abstractions at the level of
constraints, by comparing identical models with otherwise
different constraints based on gene expression, regulation, or
thermodynamics. Finally, we envision our approach being used to
examine cellular behavior under different environmental condi-
tions, or to compare evolved and un-evolved cellular phenotypes.
Ultimately, a comparative approach such as ours will enable rapid
evaluation of the influence of network and model differences on
predicted functional states.
Methods
Formulation of Bilevel Optimization Problem for
Identification of Gene Deletion Sets
The CONGA framework employs a bilevel optimization
problem to identify genetic perturbations which disproportionately
change flux through a selected reaction (e.g., growth or by-product
secretion) in one organism over another (Figure 1). The outer
problem is a mixed-integer linear program (MILP) which finds
gene deletions maximizing the flux difference between two
reactions in different models. The two inner problems (one for
each model) are flux-balance analysis (FBA) problems [64], linear
programs (LPs) which maximize growth subject to reaction
stoichiometry, thermodynamics, and enzyme capacities. We alter
the FBA problems using deletions given by the outer problem.
Gene-protein-reaction (GPR) constraints associate genes with
reactions and are used to enforce the gene deletions given by
the outer problem. These constraints are formulated using the
logical relationships developed previously [35]. CONGA can
select any genes for deletion, with the restriction that orthologous
genes present in both models be deleted simultaneously from both
models.












Each reaction j in the set of reactions j has a flux given by vj.
The FBA objective is a linear combination of fluxes
P
j cjvj, where
c is a vector of weights. We choose to maximize for biomass alone,
in which case cj is a standard basis vector along biomass, and the
objective is written as vBM. Each reaction j consumes and produces
some metabolites i in the set of metabolites I, with stoichiometry
given by Sij. By conservation of mass, net production of each
metabolite across the entire network must be zero at steady-state
(equation 2). Each reaction is constrained to have flux within an
appropriate range as given by enzyme capacities and thermody-
namics (equation 3). For reactions deleted by the outer problem, a
binary variable (yj) takes a zero value (yj~0), and the
corresponding flux vj is constrained to zero (equation 4).
On-off reaction states are given by the binary variable y and
determined by GPR constraints embedded in the outer problem:
yj~f(z^ g g,w^ p p) VGPR(j,^ p p,^ g g)[J,P,G ð5Þ
Each gene g in the set of genes G, protein p in the set of proteins
P, and reaction j in the set of reactions J has a corresponding
binary variable z, w, and y, respectively, which determines the
gene, protein, or reaction’s on-off state. (See [35] for details.) Each
reaction j with a known GPR association can be carried out by a
subset of enzymes ^ p p, and each enzyme is specified by the subset of
gene products ^ g g. The outer problem selects one or more genes for
deletion (zg~0), and the GPR constraints GPR(j,^ p p,^ g g) implement
the necessary logical relationships to determine the set of deleted
reactions (yj~0).
To identify lethal gene deletion sets, the outer problem identifies
deletions such that the growth rate of one species (A) is maximized
with respect to the other (B). So long as growth is unconstrained,
an objective of the form
max vBMA{vBMB ð6Þ
will first identify gene deletions lethal only in species B. Finally,
additional constraints are added which impose a limit K on the




and which ensure that all pairs of orthologous genes are deleted in
common:
zgA~zgB V(zgA,zgB)[O ð8Þ
The set of orthologs O contains all pairs of genes zgA and zgB
found to be orthologous between Species A and Species B.
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outer objective, and accumulating equations (1)–(5), (7), and (8) as
constraints. Equations (1)–(5) and (7) must be imposed for each
species:
max vBMA{vBMB
s:t: equations 1 ðÞ to 4 ðÞ V Species A and B
equation 5 ðÞ V Species A and B
equation 7 ðÞ V Species A and B
equation 8 ðÞ
Reformulation to Single-Level Optimization Problem
To facilitate the solution process, we reformulated the bilevel
program as single-level MILP by replacing the inner maximiza-
tion problems with their optimality conditions, in accordance
with strong duality [65]. The strong duality theorem for a linear
program states that, at optimality, the values of the primal and
dual objectives are equal, and the primal and dual variables
satisfy the primal and dual constraints, respectively [65]. Thus,
each inner problem (equations (1) to (4)) can be replaced by
formulating its dual, equating the primal and dual objectives, and
accumulating the primal and dual constraints. This reformulation
was first proposed for the bilevel strain design problem
OptKnock [66] and has since been described for other bilevel
problems [35,60,67].
This reformulation requires a new variable for each constraint
of the inner problem. Each metabolite i must satisfy the mass
balance, for which we introduce the unconstrained dual variable
u1,i. Active reactions are further constrained to be within the range
ajƒvjƒbj, for which we introduce the positive dual variables u2,j
and u3,j, respectively. In many cases, a and b are assigned large,
arbitrary values. To reduce the size of the reformulation, we
eliminated the upper bound constraint (vƒb) and imposed the
lower bound constraint (aƒv) only on uptake fluxes and
irreversible reactions, collectively the set JLL. Finally, reactions
removed by gene knockouts are constrained to zero flux, for which
we introduce a free dual variable u4,j. This allows the dual of each













Constraints (11) to (13) can be implemented using big-M
constraints [68] or using the GAMS/CPLEX indicator constraint
facility (the latter was used in this work).
The single-level formulation can then be constructed by using
equation (6) as the outer objective, equating the primal and dual
objectives (1) and (9) for each network, including constraints (2) to
(5), (7), and (10) to (14) for each network, and adding equation (8).







so that the final, single-level formulation can be expressed as:
max vBMA{vBMB
s:t: equations 2 ðÞ { 5 ðÞ ,7 ðÞ ,1 0 ðÞ { 15 ðÞ
V Species A and B
equation 8 ðÞ
We also implemented integer cut constraints [69] to allow the
generation of multiple solutions.
Modifications for Identification of Model-Dominant
Strategies
To identify model-dominant chemical production strategies in
the E. coli models, we sought gene deletions maximizing chemical
production in one model with respect to the other. For these
simulations, a few modifications from the previous formulation are
required. First, the outer objective, equation (6), was altered to
reflect chemical production flux. The vector c was changed to a
standard basis vector along the production flux of interest. We
denote this objective as vP.
max vPA{vPB ð16Þ
Some knockout conditions result in a nonunique phenotype for a
particular chemical, in which multiple chemical production values
can occur at the maximum growth rate. Under such conditions,
CONGA can artificially inflate flux differences between models,
by choosing a large production rate in one model and a small
production rate in the second. We thus imposed a tilted objective
function on each inner problem, which maximizes biomass while
imposing a small penalty (c) on chemical production; this causes
the inner problem to return the value of vP representing the lowest
expected flux through the reaction [70].
max vBM{cvP ð17Þ
Because flux values in general are not necessarily unique, this
tilted objective is necessary whenever the fluxes whose difference is
being maximzed (e.g., chemical production rates) differ from the
fluxes maximized by each model (e..g, biomass). We found this
formulation is sensitive to the value chosen for c.I fc is too small,
the tilt does not correctly return the value of vP representing the
lower bound through the reaction, and if c is too large, the tilt
returns solutions with a slightly suboptimal growth rate. For our
comparison of the E. coli models, we found that setting c~10{4
avoided both of these problems. However, the tradeoff between
growth rate and chemical production flux varies from model to
CONGA: An Automated Tool for Network Comparison
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may not be generally applicable. Modifying the inner objective in
this way requires modifying the weight vector c in equation 15 to
include the value cj~{c where j~P. We also imposed this tilted
objective function when using OptORF to identify the top deletion
strategies for each model and product.
We also constrained the dual variables associated with the
reaction deletion constraint to be between [21, 1] to improve
solver performance [35,71].
{1ƒu4,jƒ1 ð18Þ
Finally, we constrained both models to have nonzero biomass.
The final, single-level formulation can be expressed as:
max vPA{vPB
s:t: equations 2 ðÞ { 5 ðÞ ,7 ðÞ ,1 0 ðÞ { 15 ðÞ ,1 8 ðÞ
V Species A and B
vBMw0
V Species A and B
equation 8 ðÞ
A sample implementation of CONGA for the network in
Figure 2 can be found in Text S1.
Finally, we note that CONGA can be rewritten to consider a
reaction alignment and reaction deletions, by redefining the set O
(equation (8)) and using reaction instead of gene deletions
(equation (7)).
Reducing the Number of Variables
In order to reduce simulation times, we eliminated essential and
blocked genes from consideration as possible deletions by
CONGA. For each of the six models, we performed single-gene
deletions with all possible nutrients provided to the model in order
to identify essential genes (those required for cellular growth).
Genes whose orthologs were essential in both models as well as
essential genes without orthologs were then excluded from
consideration by CONGA. Flux-variability analysis (FVA) [72]
was also used, again with all possible nutrients provided, to identify
blocked reactions (those incapable of carrying flux), and genes
encoding only blocked reactions were also excluded from
consideration (i.e., if a gene encoded both a blocked and a
nonblocked reaction, CONGA was allowed to select that gene for
deletion).
For our comparison of the E. coli models, we performed
additional steps in order to improve the run-time performance of
CONGA. First, we identified essential and blocked genes (as
described above) on glucose media under anaerobic conditions
(i.e., the simulation conditions). We also removed from consider-
ation all genes associated with membrane transporters. These two
steps forced CONGA to consider only metabolic genes that can be
active under the simulation conditions. Finally, we developed a
procedure to reduce the number of genes needed to determine the
on-off state of each reaction. For a set of isozymes catalying the
same set of reactions, all but one isozyme were fixed to the off
state, such that deleting the remaining isozyme forced the set of
reactions to the off state. Likewise, for a set of subunits which are
all components of the same protein, all but one subunit were fixed
to the on state, such that deleting the remaining subunit forced the
protein to the off state. These sets of isozymes and subunits were
identified using a mixed-integer programming (MIP) approach
(Text S2). Finally, as in CONGA, orthologs present in both
models were forced to have the same state. This ensures an
internally consistent selection of isozymes and subunits (e.g., if one
member of an ortholog pair is fixed to the on (or off) state, the
other must be also). The complete set of isozyme and subunit sets
for the two E. coli models can be found in Dataset S3. The same
genes that were fixed to be on or off in CONGA were also fixed to
be on or off in the OptORF simulations used to identify the top
deletion strategies for each model and product.
Identification of Orthologs
A gene-based alignment of two networks requires a method for
identifying orthologous genes between two genomes. Since the E.
coli simulations studied two models of the same organism, we were
able to immediately match gene loci. For the cyanobacterial
simulations, we used the set of bidirectional best-BLAST hits
identified during the first step of the iSyp611 reconstruction
process. Genes added during the manual reconstruction process
were checked against the final iCce806 model, and additional
orthologs were identified. For the pathogen studies, we used SEED
to identify orthologs, as this method identified the smallest number
of false positive ortholog pairs (Table 6 and Discussion). A full
summary of ortholog pairs used in each simulation can be found in
Dataset S3.
Construction of the iSyp611 Metabolic Network
We have formulated a genome-scale network reconstruction of
the photosynthetic cyanobacterium Synechococcus sp. PCC 7002
consisting of 611 genes, 533 proteins, 552 reactions, and 542
metabolites (Table 7). A total of 517 reactions (94%) are associated
with genes and proteins, represented by gene-protein-reaction
(GPR) associations.
The model was constructed from a draft version of the iCce806
reconstruction of Cyanothece sp. ATCC 51142 via a gene-level
comparison. The Synechococcus sp. PCC 7002 genome sequence was
downloaded from the GenBank database at the National Center
for Biotechnology Information (NCBI) website [73]. A bidirec-
tional best-BLAST search was used to identify potential orthologs
between the two genomes. The validity of the associations was
manually assessed using annotation information available from
NCBI, KEGG, [12], and SEED [13]. For those genes deemed
highly probable orthologs, protein and reaction associations were
copied from the iCce806 model to create a draft reconstruction
using SimPheny (Genomatica Inc., San Diego, CA).
After assembling the draft network, missing functions were
added to ensure production of all biomass components. Candidate
reactions were selected based on pathways in other cyanobacterial
strains. Potential genes for these reactions were located by best-hit
BLAST analysis against other cyanobacterial genomes as well as
annotation information obtained from NCBI, KEGG, and SEED.
In cases where genomic information was unavailable, reactions
were selected based on their frequency of occurrence in related
strains. This draft model contained 542 genes, of which 497 were
orthologous to genes in Cyanothece (Table 7).
We also applied CONGA to our draft reconstruction, and use
the results to add new subunits and isozymes to existing reactions.
In all, nearly 70 genes were added to the reconstruction. A
complete list of reactions and GPR associations in the iSyp611
model is included in the Supporting Information, in Microsoft
Excel and SBML formats (Datasets S1 and S2).
Wherever possible, the reactions used to represent RNA, DNA,
protein, fatty acid, and lipid synthesis were updated to reflect the
particulars of Synechococcus sp. PCC 7002. DNA and RNA
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composition was obtained from amino acid counts of the
proteome. Fatty acid composition was taken from Synechococcus
sp. PCC 7002 [74,75], and lipid composition was taken from
Synechococcus sp. PCC 7942 [76]. The biomass equation was
formulated using weight fractions of macromolecules (DNA, RNA,
protein, lipid, fatty acids, glycogen) measured from Synechosystis sp.
PCC 6803 in batch culture [77], and the composition of the
soluble pool was copied from the iJR904 model [15].
The final metabolic reconstruction was used to formulate a
constraint-based model of Synechococcus metabolism. Experimen-
tally, Synechococcus is able to grow phototrophically using light,
carbon dioxide, and ammonium. Our constraint-based model was
capable of predicting growth under photoautotrophic and glycerol
heterotrophic conditions via FBA.
Models and Simulation Conditions
The CONGA analysis of the two published models of E. coli,
iJR904 [15] and iAF1260 [16] were performed under anaerobic,
glucose-limited conditions (uptake rate 18.5 mmol/gDW/hr). All
reported chemical production levels were normalized to the
theoretical maximum (2 mol ethanol/mol glucose, 2 mol lactate/
mol glucose, and 1.71 mol succinate/mol glucose).
For the iSyp611 and iCce806 comparisons, several reactions in
the iSyp611 model were replaced with their iCce806 equivalents,
including biomass, ATP synthase, DNA, RNA, lipid, and protein
synthesis, and cytochrome oxidases unique to Cyanothece (Dataset
S2). Simulations were performed under carbon-limited photoau-
totrophic conditions, with maximum uptake fluxes for photons for
both photosystems, carbon dioxide, and ammonium constrained
to 100 mmol photons/gDW/hr, 20 mmol/gDW/hr, and
10 mmol/gDW/hr, respectively. Unconstrained uptake of inor-
ganic phosphate, oxygen, magnesium(II), protons, sulfate, and
water was also allowed. Growth-associated and non-growth
associated ATP maintenance requirements were set to zero.
For the iNJ661 and iSB619 models, simulations were performed
on nine distinct minimal media with different carbon and nitrogen
sources (Dataset S2). The set of gene deletion sets common to all
conditions was then analyzed for potential drug targets.
All simulations were performed using CPLEX 12 (IBM,
Armonk, NY) accessed via the General Algebraic Modeling
System (GAMS, GAMS Development Corporation, Washington,
DC). Simulations were performed on a Red Hat Enterprise Linux
server with 2.66 GHz Intel Xeon processors and 8 GB of RAM.
CONGA can identify a lethal gene deletion set containing just one
gene in less than a second. Lethal gene deletion sets containing two
or three genes took on average 3 minutes to identify. Identifying
model-dominant chemical production strategies is more time-
consuming, with a model-dominant strategy containing two genes
requiring on average 2 minutes. Model-dominant strategies
containing three, four, or five genes took an average of 15 minutes,
75 minutes, and 5 hours to identify, respectively. A full summary
of differences identified by each simulation can be found in
Dataset S3.
Supporting Information
Figure S1 Model-dominant production strategies for
lactate. (A) Deletion strategies for lactate production. Each bar
represents the absolute difference in predicted lactate yields
between the iJR904 and iAF1260 models as a fraction of the
maximum theoretical yield (2 lactate/glucose). Left side: Strategies
for which the iAF1260 model predicts higher production. Right
side: Strategies for which the iJR904 model predicts higher
production. Corresponding gene deletion strategies involving 3, 4,
or 5 genes are given below the figure. Numbers above each bar
indicate the fraction of the theoretical maximum yield obtained by
each model, with the dominant model listed first. Some strategies
have a nonunique lactate production phenotype, in which multiple
lactate production values can occur at the maximum growth rate.
For these scenarios, the production difference calculated by
CONGA is from the lowest expected level of lactate production
in each model, and such strategies are indicated in green.
Strategies for which the yield of the dominant model meets or
exceeds the yield for the third-best OptORF strategy for that
model are known as OptORF strategies, and such strategies are
indicated in red. OptORF strategies which also have a nonunique
production phenotype are indicated in orange. (B) The same gene
deletion strategies after reconciliation of the iJR904 and iAF1260
networks with respect to metabolic differences.
(PDF)
Figure S2 Model-dominant production strategies for
succinate. (A) Deletion strategies for succinate production. Each
bar represents the absolute difference in predicted succinate yields
between the iJR904 and iAF1260 models as a fraction of the
maximum theoretical yield (1.71 succinate/glucose). Left side:
Strategies for which the iAF1260 model predicts higher produc-
tion. Right side: Strategies for which the iJR904 model predicts
higher production. Corresponding gene deletion strategies involv-
ing 2, 3, or 4 genes are given below the figure. Genes enclosed in
parentheses indicate a deletion unique to the iAF1260 model.
Numbers above each bar indicate the fraction of the theoretical
maximum yield obtained by each model. Strategies for which the
yield of the dominant model meets or exceeds the yield for the
third-best OptORF strategy for that model are known as OptORF
strategies, and such strategies are indicated in red. (B) The same
gene deletion strategies after reconciliation of the iJR904 and
iAF1260 networks with respect to metabolic differences.
(PDF)
Figure S3 Differences in metabolic pathways in E. coli
GENREs. The text above each map indicates the pathway
responsible for the phenotypic difference, the phenotype with
which the strategy is associated, and the gene deletion for which
the phenotype occurs. (A–C) Schematic views of the flux
distributions associated with the indicated gene deletion set.
Metabolites are represented in plain text. Metabolites are
represented in plain text. Metabolic transformations are indicated
via arrows, with thicker arrows indicating higher flux. In some
instances, multiple transformations are combined into a single
dashed arrow. Fluxes active in the iAF1260 network are in red,








Genes (Orthologs) 542 (497) 611 (529) 806 (529)
Proteins 461 533 690
Reactions 491 552 667
Reactions w/GPRs 491 517 625
Metabolites 529 542 587
The draft and final reconstructions of the iSyp611 model differ considerably in
size. The size of the iCce806 model is given as a point of reference.
doi:10.1371/journal.pone.0034670.t007
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PLoS ONE | www.plosone.org 17 April 2012 | Volume 7 | Issue 4 | e34670fluxes active in the iJR904 network are in blue, and inactive fluxes
are in grey. If gene (reaction) deletions occur in the fermentation
pathway, they are indicated by black ‘X’s. Fluxes crossing the
dashed boundary indicate transport to the extracellular environ-
ment. Metabolite abbreviations: 2aobut, L-2-Amino-3-oxobutano-
ate; actp, acetyl phosphate; athr, allo-threonine; glc, glucose. All
other abbreviations match those used in the iSyp611 metabolic
model (see Additional File 2). (A) As a consequence of growth, E.
coli produces protons which must be consumed by reactions in the
network or secreted into the media. The succinate (succ) antiporter
in the iAF1260 model makes succinate transport energetically
unfavorable, so flux is instead diverted to ethanol (etoh). (B) This
knockout eliminates ATP synthase, necessary for pumping protons
into the cytosol. Deletion of ATP synthase forces protons to be
consumed via the fermentation reactions. The ability of the
iAF1260 model to transport H2 allows it to utilize formate
hydrogen lyase for this purpose. As a consequence, flux is diverted
away from ethanol to CO2. This effect becomes more pronounced
as additional genes are deleted. (C) Wild-type FBA predicts that
both E. coli models uptake glucose via the phosphotransferase
system (PTS), and convert the resulting glucose-6-phosphate (g6p)
to fructose-6-phosphate (f6p). The deletion of pgi prevents this
transformation. The iAF1260 network contains an additional
hexokinase which allows it to bypass the deletion by bypassing the
PTS. The iJR904 model lacks this reaction and is forced to use
PTS. The deletion of edd then forces the iJR904 network to
metabolize glucose via the oxidative branch of the pentose
phosphate pathway. This process generates electrons, leading to
higher levels of fermentation products than in the iAF1260 model.
(PDF)
Dataset S1 SBML version of the iSyp611 model.
(XML)
Dataset S2 Microsoft Excel versions of the iSyp611
model. Description of stoichiometric and annotation changes
made to each of the six metabolic models examined over the
course of this study.
(XLSX)
Dataset S3 Computational results of all simulations.
This Microsoft Excel file contains 1) the simulation conditions for
each study, 2) the full results of all CONGA simulations performed
in this study, 3) all ortholog assignments used in performing the
CONGA simulations, and 4) results from each ortholog calling
method applied to the human pathogen models.
(XLSX)
Text S1 Sample implementation of CONGA formula-
tion in GAMS format. A free demo version of GAMS can be
downloaded from http://www.gams.com. This file contains the
example network described in Figure 2.
(GMS)
Text S2 Variable Reduction Procedure. This section
contains additional details about the algorithm used to decrease
the number of genes considered by CONGA.
(PDF)
Acknowledgments
The authors wish to thank Trang Vu for insightful discussions, and
Joonhoon Kim and Chris Tervo for comments on the manuscript.
Author Contributions
Conceived and designed the experiments: JJH JLR. Performed the
experiments: JJH. Analyzed the data: JJH JLR. Wrote the paper: JJH
JLR. Conceived the mixed-integer programming approach: JJH JLR.
Implemented the mixed-integer programming approach: JJH.
References
1. Feist AM, Herrgard MJ, Thiele I, Reed JL, Palsson BO (2009) Reconstruction of
biochemical networks in microorganisms. Nature Reviews: Microbiology 7:
129–143.
2. Oberhardt MA, Palsson BO, Papin JA (2009) Applications of genome-scale
metabolic reconstructions. Molecular Systems Biology 5: 320.
3. Price ND, Reed JL, Palsson BO (2004) Genome-scale models of microbial cells:
evaluating the consequences of constraints. Nature Reviews: Microbiology 2:
886–897.
4. Archer CT, Kim JF, Jeong H, Park JH, Vickers CE, et al. (2011) The genome
sequence of E. coli W (ATCC 9637): comparative genome analysis and an
improved genome-scale reconstruction of E. coli. BMC Genomics 12: 9.
5. Kim HU, Kim SY, Jeong H, Kim TY, Kim JJ, et al. (2011) Integrative genome-
scale metabolic analysis of Vibrio vulnificus for drug targeting and discovery.
Molecular Systems Biology 7: 460.
6. Henry CS, DeJongh M, Best AA, Frybarger PM, Linsay B, et al. (2010) High-
throughput generation, optimization and analysis of genome-scale metabolic
models. Nature Biotechnology 28: 969–974.
7. Herrgard MJ, Swainston N, Dobson PD, Dunn WB, Arga KY, et al. (2008) A
consensus yeast metabolic network reconstruction obtained from a community
approach to systems biology. Nature Biotechnology 26: 1155–1160.
8. Thiele I, Hyduke DR, Steeb B, Fankam G, Allen DK, et al. (2011) A community
effort towards a knowledge-base and mathematical model of the human
pathogen Salmonella Typhimurium LT2. BMC Systems Biology 5: 8.
9. Oberhardt MA, Puchaka J, Martins dos Santos VAP, Papin JA (2011)
Reconciliation of Genome-Scale Metabolic Reconstructions for Comparative
Systems Analysis. PLoS Computational Biology 7: e1001116.
10. Schellenberger J, Park JO, Conrad TM, Palsson BO (2010) BiGG: a
Biochemical Genetic and Genomic knowledgebase of large scale metabolic
reconstructions. BMC Bioinformatics 11: 213.
11. Caspi R, Altman T, Dale JM, Dreher K, Fulcher CA, et al. (2010) The MetaCyc
database of metabolic pathways and enzymes and the BioCyc collection of
pathway/genome databases. Nucleic Acids Research 38: D473–D479.
12. Kanehisa M, Goto S (2000) KEGG: kyoto encyclopedia of genes and genomes.
Nucleic Acids Research 28: 27–30.
13. Overbeek RA, Begley T, Butler RM, Choudhuri JV, Chuang HY, et al. (2005)
The subsystems approach to genome annotation and its use in the project to
annotate 1000 genomes. Nucleic Acids Research 33: 5691–5702.
14. Karp PD, Paley SM, Krummenacker M, Latendresse M, Dale JM, et al. (2010)
Pathway Tools version 13.0: integrated software for pathway/genome
informatics and systems biology. Briefings in Bioinformatics 11: 40–79.
15. Reed JL, Vo TD, Schilling CH, Palsson BO (2003) An expanded genome-scale
model of Escherichia coli K-12 (iJR904 GSM/GPR). Genome Biology 4: R54.
16. Feist AM, Henry CS, Reed JL, Krummenacker M, Joyce AR, et al. (2007) A
genome-scale metabolic reconstruction for Escherichia coli K-12 MG1655 that
accounts for 1260 ORFs and thermodynamic information. Molecular Systems
Biology 3: 121.
17. Covert MW, Knight EM, Reed JL, Herrgard MJ, Palsson BO (2004) Integrating
high-throughput and computational data. Nature 429: 92–96.
18. Reed JL, Patel TR, Chen KH, Joyce AR, Applebee MK, et al. (2006) Systems
approach to refining genome annotation. Proceedings of the National Academy
of Sciences of the United States of America 103: 17480–17484.
19. Fong SS, Burgard AP, Herring CD, Knight EM, Blattner FR, et al. (2005) In
silico design and adaptive evolution of Escherichia coli for production of lactic
acid. Biotechnology and Bioengineering 91: 643–648.
20. Alper H, Jin YS, Moxley JF, Stephanopoulos GN (2005) Identifying gene targets
for the metabolic engineering of lycopene biosynthesis in Escherichia coli.
Metabolic Engineering 7: 155–164.
21. Lee SJ, Lee DY, Kim TY, Kim BH, Lee J, et al. (2005) Metabolic engineering of
Escherichia coli for enhanced production of succinic acid, based on genome
comparison and in silico gene knockout simulation. Applied and Environmental
Microbiology 71: 7880–7887.
22. Singh A, Cher Soh K, Hatzimanikatis V, Gill RT (2011) Manipulating redox
and ATP balancing for improved production of succinate in E. coli. Metabolic
Engineering 13: 76–81.
23. Vu T, Stolyar SM, Pinchuk GE, Hill EA, Kucek LA, et al. (1142) Genome-Scale
Modeling of Light-Driven Reductant Partitioning and Carbon Fluxes in
Diazotrophic Unicellular Cyanobacterium Cyanothece sp. ATCC 51142. PLoS
Computational Biologyin press.
24. Atsumi S, Higashide W, Liao JC (2009) Direct photosynthetic recycling of
carbon dioxide to isobutyraldehyde. Nature Biotechnology 27: 1177–1180.
25. Lindberg P, Park S, Melis A (2010) Engineering a platform for photosynthetic
isoprene production in cyanobacteria, using Synechocystis as the model
organism. Metabolic Engineering 12: 70–79.
CONGA: An Automated Tool for Network Comparison
PLoS ONE | www.plosone.org 18 April 2012 | Volume 7 | Issue 4 | e3467026. Liu X, Sheng J, Curtiss III R (2011) Fatty acid production in genetically
modified cyanobacteria. Proceedings of the National Academy of Sciences of the
United States of America 108: 6899–6904.
27. Tan X, Yao L, Gao Q, Wang W, Qi F, et al. (2011) Photosynthesis driven
conversion of carbon dioxide to fatty alcohols and hydrocarbons in
cyanobacteria. Metabolic Engineering 13: 169–176.
28. Jamshidi N, Palsson BO (2007) Investigating the metabolic capabilities of
Mycobacterium tuberculosis H37Rv using the in silico strain iNJ661 and
proposing alternative drug targets. BMC Systems Biology 1: 26.
29. Becker SA, Palsson BO (2005) Genome-scale reconstruction of the metabolic
network in Staphylococcus aureus N315: an initial draft to the two-dimensional
annotation. BMC Microbiology 5: 8.
30. Lange RP, Locher HH, Wyss PC, Then RL (2007) The targets of currently used
antibacterial agents: lessons for drug discovery. Current Pharmaceutical Design
13: 3140–3154.
31. Neu HC (1992) The Crisis in Antibiotic Resistance. Science 257: 1064–1073.
32. Hancock REW (2005) Mechanisms of action of newer antibiotics for Gram-
positive pathogens. The Lancet Infectious Diseases 5: 209–218.
33. Walsh CT (2003) Where will new antibiotics come from? Nature Reviews:
Microbiology 1: 65–70.
34. Bumann D (2008) Has nature already identified all useful antibacterial targets?
Current Opinion in Microbiology 11: 387–392.
35. Kim J, Reed JL (2010) OptORF: Optimal metabolic and regulatory
perturbations for metabolic engineering of microbial strains. BMC Systems
Biology 4: 53.
36. Feist AM, Palsson BO (2008) The growing scope of applications of genome-scale
metabolic reconstructions using Escherichia coli. Nature Biotechnology 26:
659–667.
37. Fu P (2009) Genome-scale modeling of Synechocystis sp. PCC 6803 and
prediction of pathway insertion. Journal of Chemical Technology & Biotech-
nology 84: 473–483.
38. Knoop H, Zilliges Y, Lockau W, Steuer R (2010) The metabolic network of
Synechocystis sp. PCC 6803: Systemic properties of autotrophic growth. Plant
Physiology 154: 410–422.
39. Montagud A, Navarro E, Fernandez de Cordoba P, Urchueguia JF, Patil KR
(2010) Reconstruction and analysis of genome-scale metabolic model of a
photosynthetic bacterium. BMC Systems Biology 4: 156.
40. Duarte NC, Becker SA, Jamshidi N, Thiele I, Mo ML, et al. (2007) Global
reconstruction of the human metabolic network based on genomic and bibliomic
data. Proceedings of the National Academy of Sciences of the United States of
America 104: 1777–1782.
41. Wright GD, Walsh CT (1992) D-Alanyl-D-alanine Ligases and the Molecular
Mechanism of Vancomycin Resistance. Accounts of Chemical Research 25:
468–473.
42. Blanchard JS (1996) Molecular Mechanisms of Drug Resistance in Mycobac-
terium Tuberculosis. Annual Review of Biochemistry 65: 215–239.
4 3 .Z i m h o n yO ,C o xJ S ,W e l c hJ T ,V i l c h e ` z eC ,J a c o b sW R ,J r .( 2 0 0 0 )
Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of
Mycobacterium tuberculosis. Nature Medicine 6: 1043–1047.
44. Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z (2003) Mode of action of
pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport
and energetics by pyrazinoic acid. The Journal of Antimicrobial Chemotherapy
52: 790–795.
45. He X, Reynolds KA (2002) Purification, Characterization, and Identification of
Novel Inhibitors of the Beta-Ketoacyl-Acyl Carrier Protein Synthase III (FabH)
from Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 46:
1310–1318.
46. Nie Z, Perretta C, Lu J, Su Y, Margosiak S, et al. (2005) Structure-based design,
synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein
synthase III as potential antimicrobial agents. Journal of Medicinal Chemistry
48: 1596–1609.
47. Arora P, Goyal A, Natarajan VT, Rajakumara E, Tyagi A, et al. (2009)
Mechanistic and functional insights into fatty acid activation in Mycobacterium
tuberculosis. Nature Chemical Biology 5: 166–173.
48. Lyon BR, Skurray R (1987) Antimicrobial resistance of Staphylococcus aureus:
genetic basis. Microbiological Reviews 51: 88–134.
49. French JB, Cen Y, Vrablik TL, Xu P, Allen E, et al. (2010) Characterization of
nicotinamidases: steady state kinetic parameters, classwide inhibition by
nicotinaldehydes, and catalytic mechanism. Biochemistry 49: 10421–10439.
50. Neres Ja, Labello NP, Somu RV, Boshoff HIM, Wilson DJ, et al. (2008)
Inhibition of siderophore biosynthesis in Mycobacterium tuberculosis with
nucleoside bisubstrate analogues: structureactivity relationships of the nucleo-
base domain of 59-O-[N-(salicyl)sulfamoyl]adenosine. Journal of Medicinal
Chemistry 51: 5349–5370.
51. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local
alignment search tool. Journal of Molecular Biology 215: 403–410.
52. Li L, Stoeckert CJ, Jr., Roos DS (2003) OrthoMCL : Identification of ortholog
groups for eukaryotic genomes. Genome Research 13: 2178–2189.
53. Raghunathan A, Reed JL, Shin S, Palsson BO, Daeer S (2009) Constraint-based
analysis of metabolic capacity of Salmonella typhimurium during host-pathogen
interaction. BMC Systems Biology 3: 38.
54. Sun J, Sayyar B, Butler JE, Pharkya P, Fahland TR, et al. (2009) Genome-scale
constraint-based modeling of Geobacter metallireducens. BMC Systems Biology
3: 15.
55. Pinchuk GE, Hill EA, Geydebrekht OV, De Ingeniis J, Zhang X, et al. (2010)
Constraint-Based Model of Shewanella oneidensis MR-1 Metabolism: A Tool
for Data Analysis and Hypothesis Generation. PLoS Computational Biology 6:
e1000822.
56. Sun J, Haveman SA, Bui OT, Fahland TR, Lovley DR (2010) Constraint-based
modeling analysis of the metabolism of two Pelobacter species. BMC Systems
Biology 4: 174.
57. Satish Kumar V, Ferry JG, Maranas CD (2011) Metabolic reconstruction of the
archaeon methanogen Methanosarcina Acetivorans. BMC Systems Biology 5:
28.
58. Pharkya P, Burgard AP, Maranas CD (2004) OptStrain : A computational
framework for redesign of microbial production systems. Genome Research 14:
2367–2376.
59. Patil KR, Rocha I, Fo ¨rster J, Nielsen J (2005) Evolutionary programming as a
platform for in silico metabolic engineering. BMC Bioinformatics 6: 308.
60. Pharkya P, Maranas CD (2006) An optimization framework for identifying
reaction activation/inhibition or elimination candidates for overproduction in
microbial systems. Metabolic Engineering 8: 1–13.
61. Lun DS, Rockwell G, Guido NJ, Baym M, Kelner JA, et al. (2009) Large-scale
identification of genetic design strategies using local search. Molecular Systems
Biology 5: 296.
62. Ranganathan S, Suthers PF, Maranas CD (2010) OptForce: An optimization
procedure for identifying all genetic manipulations leading to targeted
overproductions. PLoS Computational Biology 6: e1000744.
63. Yang L, Cluett WR, Mahadevan R (2011) EMILiO: A Fast Algorithm for
Genome-Scale Strain Design. Metabolic Engineering 13: 272–281.
64. Orth JD, Thiele I, Palsson BO (2010) What is ux balance analysis? Nature
Biotechnology 28: 245–248.
65. Ferris MC, Mangasarian OL, Wright SJ (2008) Linear Programming with
Matlab. Society for Industrial Mathematics. 280 p.
66. Burgard AP, Pharkya P, Maranas CD (2003) OptKnock: a bilevel programming
framework for identifying gene knockout strategies for microbial strain
optimization. Biotechnology and Bioengineering 84: 647–657.
67. Tepper N, Shlomi T (2010) Predicting metabolic engineering knockout strategies
for chemical production: accounting for competing pathways. Bioinformatics 26:
536–543.
68. Williams HP (1999) Model Building in Mathematical Programming. Wiley, 4
edition. 368 p.
69. Burgard AP, Vaidyaraman S, Maranas CD (2001) Minimal reaction sets for
Escherichia coli metabolism under different growth requirements and uptake
environments. Biotechnology Progress 17: 791–797.
70. Feist AM, Zielinski DC, Orth JD, Schellenberger J, Herrgard MJ, et al. (2010)
Model-driven evaluation of the production potential for growth-coupled
products of Escherichia coli. Metabolic Engineering 12: 173–186.
71. Kim J, Reed JL, Maravelias CT (2011) Large-scale bi-level strain design
approaches and mixedinteger programming solution techniques. PloS ONE 6:
e24162.
72. Mahadevan R, Schilling CH (2003) The effects of alternate optimal solutions in
constraint-based genome-scale metabolic models. Metabolic Engineering 5:
264–276.
73. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW (2010)
GenBank. Nucleic Acids Research 39: 32–37.
74. Murata N, Wadat H (1995) Acyl-lipid desaturases and their importance in the
tolerance and acclimatization to cold of cyanobacteria. Biochemical Journal 308:
1–8.
75. Sakamoto T, Shen G, Higashi S, Murata N, Bryant DA (1998) Alteration of low-
temperature susceptibility of the cyanobacterium Synechococcus sp. PCC 7002
by genetic manipulation of membrane lipid unsaturation. Archives of
Microbiology 169: 20–28.
76. Benning C (1998) Biosynthesis and function of the sulfolipid sulfoquinovosyl
diacylglycerol. Annual Review of Plant Physiology and Plant Molecular Biology
49: 53–75.
77. Shastri AA, Morgan JA (2005) Flux balance analysis of photoautotrophic
metabolism. Biotechnology Progress 21: 1617–1626.
CONGA: An Automated Tool for Network Comparison
PLoS ONE | www.plosone.org 19 April 2012 | Volume 7 | Issue 4 | e34670